Tuesday 3 November 2026
Export MOH’s income statement to Excel — free account
Molina Healthcare, Inc
MOH Healthcare Healthcare Plans
Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024.
- Revenue
- −3.44%
- EPS
- −51.7%
- Free cash flow
- −20.3%
- Total debt
- +2.54%
Quarter to September 2026, against a year earlier
209.31
0.86
+0.41%
Follow MOH
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 6 | 4 |
+8 more TTM periods Free account |
| (1.15%) | (0.16%) | 4.48% | 11.02% | ||
| (0.31%) | (0.04%) | 1.15% | 3.03% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(0.88%) | (0.13%) | 3.46% | 8.78% | |
Average Days of Receivables |
27.78 | 28.57 | 27.69 | 28.39 | |
Free Cash Flow per Share |
4.65 | 5.30 | 4.93 | (12.05) | |
Free Cash Flow |
238.00 | 271.00 | 251.00 | (636.00) | |
Capital Expenditures |
(93.00) | (94.00) | (106.00) | (101.00) | |
| Other line items | |||||
Cash ROIC |
1.43% | 1.59% | 1.45% | (3.91%) | |
Accounts Receivable Turnover |
12.84 | 12.11 | 13.04 | 13.30 | |
Accounts Payable Turnover |
33.43 | 34.54 | 34.46 | 32.58 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
11.20 | 10.69 | 10.79 | 10.10 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.17 | 0.17 | (0.18) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.82% | 6.80% | 6.69% | 6.62% | |
Share Based Compensation of Revenue |
0.24% | 0.17% | 0.12% | 0.10% | |
Interest Coverage |
0.81 | 0.97 | 2.12 | 4.07 | |
Operating CF/Net income |
(6.90) | (52.14) | 1.90 | (1.13) | |
Depreciation/Fixed assets |
0.50 | 0.54 | 0.62 | 0.65 | |
Capex/Depreciation |
(0.58) | (0.56) | (0.57) | (0.52) | |
Revenue per Share |
861.86 | 871.27 | 885.56 | 860.34 | |
Operating CF per Share |
6.46 | 7.14 | 7.01 | (10.13) | |
Capex per Share |
(1.82) | (1.84) | (2.08) | (1.91) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026